TYRO3/MERTK

Deyu Kong1, Jichen Zhao1, Daowei Huang1

  • 1Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

PubMed
概括

研究人员发现了UNC9435,这是第一个针对TYRO3和MERTK受体氨酸激酶的强有力的双重抑制剂. 这种新化合物对治疗依赖于这些特定致癌途径的癌症具有前途.